Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Rama Melkote"'
Autor:
Ella Daly, Vanina Popova, Adam Janik, Crystal Wylie, Richard L. Doty, Carol Jamieson, Rosanne Lane, Rama Melkote, Pilar Lim, Kim Cooper, Rachel Ochs-Ross, Wayne C. Drevets, Maggie Fedgchin, Jaskaran Singh
Publikováno v:
CNS Drugs
Background Intranasal drug delivery offers a non-invasive and convenient dosing option for patients and physicians, especially for conditions requiring chronic/repeated-treatment administration. However, in some cases such delivery may be harmful to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6782881d0b251255850def10749a728f
http://europepmc.org/articles/PMC8310483
http://europepmc.org/articles/PMC8310483
Publikováno v:
CNS Drugs
Background An intranasal formulation of esketamine, combined with an oral antidepressant, is approved in the USA and the European Union for adults with treatment-resistant depression (TRD). Transient cardiovascular stimulatory effects have been repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69b4c1507350bb8e9b3f928576abf7c4
https://doi.org/10.1007/s40263-020-00699-4
https://doi.org/10.1007/s40263-020-00699-4
Publikováno v:
SCHIZOPHRENIA RESEARCH
Objective Antipsychotic blood levels (ABLs) may help identify patients at risk for treatment failure. Reference ranges (RR) for plasma concentrations of ABLs that account for between-patient variability were developed for risperidone and olanzapine b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6699b5af1a82e0aa60348ad67391124
https://doi.org/10.1016/j.schres.2018.05.028
https://doi.org/10.1016/j.schres.2018.05.028
Autor:
Husseini Manjii, Hans van den Ameele, Dawn Vitagliano, Pierre Blier, Maurizio Fava, Rosanne Lane, Wayne C. Drevets, David Hough, Pilar Lim, Michael R. Liebowitz, Madhukar H. Trivedi, Ella J. Daly, Arun V. Ravindran, Raphaël Gaillard, Jaskaran Singh, Maggie Fedgchin, Rama Melkote
Publikováno v:
Journal of Affective Disorders. 254:131-132
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::30bea08c2e045948b49d5adb0b6fa932
https://doi.org/10.1016/j.jad.2018.10.289
https://doi.org/10.1016/j.jad.2018.10.289
Autor:
Ralph Riley, Rama Melkote, Adam Savitz, David J. Williamson, Maria A Pobre, Kelly McQuarrie, Benjamin Banderas
Publikováno v:
Psychiatry research. 267
The cause of treatment failure of antipsychotic medications is often difficult to determine in patients with schizophrenia. Evaluation of antipsychotic blood levels (ABLs) may aid clinicians in determining the cause of antipsychotic failure. The Clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8529e6509018ffca71372efc46f3a583
https://pubmed.ncbi.nlm.nih.gov/29879602
https://pubmed.ncbi.nlm.nih.gov/29879602
Autor:
Danielle, Coppola, Rama, Melkote, Caroline, Lannie, Jaskaran, Singh, Isaac, Nuamah, Srihari, Gopal, David, Hough, Joseph, Palumbo
Publikováno v:
Psychopharmacology bulletin. 44(2)
Paliperidone extended-release (paliperidone ER) is an approved oral antipsychotic medication (dosing range 3-12 mg/day) for treatment of schizophrenia and schizoaffective disorder in adults.In this 3-arm, double-blind, placebo- and active-controlled,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a2178c57bba9ba55516cafe034ac249
https://pubmed.ncbi.nlm.nih.gov/27738355
https://pubmed.ncbi.nlm.nih.gov/27738355
Publikováno v:
Journal of Affective Disorders. 138:247-258
Paliperidone ER monotherapy was efficacious in treating acute mania in two 3-week studies in patients with bipolar I disorder. We assessed its efficacy in a study investigating maintenance treatment of clinically stable patients with this disorder.Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::512598eb2e75d750533787a7e28ad689
https://doi.org/10.1016/j.jad.2012.01.047
https://doi.org/10.1016/j.jad.2012.01.047
Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia
Autor:
Virginie Herben, Pilar Lim, Srihari Gopal, Rama Melkote, Eric Yuen, Jean-Pierre Lindenmayer, David Hough, Mariëlle Eerdekens
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 33:1022-1031
Paliperidone palmitate is an investigational, injectable atypical antipsychotic. The safety and tolerability of initiating treatment with paliperidone palmitate via deltoid versus gluteal injections given once monthly, and of switching injection site
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c85f9004a24613ffb29d2bdd68163dab
https://doi.org/10.1016/j.pnpbp.2009.05.014
https://doi.org/10.1016/j.pnpbp.2009.05.014
Autor:
Gary J. Noel, Adriano Arguedas, John S. Bradley, Xavier Sáez-Llorens, Rama Melkote, Jeffrey L. Blumer
Publikováno v:
Pediatric Infectious Disease Journal. 26:868-878
Background: Levofloxacin has established efficacy and safety in the treatment of community-acquired pneumonia (CAP) in adults, and its use as an alternative therapy for children with CAP has been proposed. Objective: Assess the clinical efficacy and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff6c911fdbd7b0018485474b2ba272d6
https://doi.org/10.1097/inf.0b013e3180cbd2c7
https://doi.org/10.1097/inf.0b013e3180cbd2c7
Autor:
Adriano Arguedas, Ron Dagan, Jeffery Blumer, Michael E. Pichichero, Eugene Leibovitz, David F. McNeeley, Rama Melkote, Gary J. Noel
Publikováno v:
The Pediatric Infectious Disease Journal. 25:1102-1109
Levofloxacin has excellent activity against common respiratory pathogens and therefore is likely to be effective in treating children with persistent or recurrent otitis media.The objective of this study was to assess the efficacy and safety of levof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dae70301441ecbc01f7863f6a845c28
https://doi.org/10.1097/01.inf.0000246828.13834.f9
https://doi.org/10.1097/01.inf.0000246828.13834.f9